View in EDS

LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque.

Saved in:
Bibliographic Details
Title: LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque.
Authors: Boada CA; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States.; Tecnológico de Monterrey, Escuela de Ingeniería y Ciencias, México, Mexico., Zinger A; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States.; Department of Engineering Medicine, Texas A&M University, Houston, TX, United States.; Laboratory for Bioinspired NanoEngineering and Translational Therapeutics, Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa, Israel., Rohen S; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States., Martinez JO; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States., Evangelopoulos M; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States., Molinaro R; IRCCS Ospedale San Raffaele srl, Milan, Italy.; Department of Biomedical Engineering, University of Houston, Houston, TX, United States., Lu M; Department of Biomedical Engineering, University of Houston, Houston, TX, United States., Villarreal-Leal RA; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States.; Tecnológico de Monterrey, Escuela de Ingeniería y Ciencias, México, Mexico., Giordano F; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States.; Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, United States., Sushnitha M; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States., De Rosa E; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States., Simonsen JB; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark., Shevkoplyas S; Department of Biomedical Engineering, University of Houston, Houston, TX, United States., Taraballi F; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, United States.; Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, United States., Tasciotti E; San Raffaele University, Rome and IRCCS San Raffaele Hospital, Rome, Italy.
Source: Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Dec 01; Vol. 9, pp. 794676. Date of Electronic Publication: 2021 Dec 01 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-4185
DOI:10.3389/fbioe.2021.794676